293 results
Page 5 of 15
8-K
EX-99.1
cxh6 3eno3mx1
29 May 20
Cardiff Oncology Data Continues to Demonstrate Efficacy of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer Presented at ASCO
12:00pm
8-K
EX-99.1
5zuuc25g
28 May 20
Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
11:50am
8-K
EX-10.1
4bxebkq4bue8 om1m
27 May 20
Cardiff Oncology Announces $2.5 Million Equity Investment by Biotech-Focused Fundamental Investor Acorn Bioventures
11:07am
8-K
EX-99.1
2ng6 ppyqa9k22dvj
27 May 20
Cardiff Oncology Announces $2.5 Million Equity Investment by Biotech-Focused Fundamental Investor Acorn Bioventures
11:07am
8-K
EX-99.1
ic56s 5lwne42eufwcj
19 May 20
Cardiff Oncology Announces Private Placement Investment by Board of Directors and Chief Executive Officer
9:28am
8-K
EX-99.1
qcn4mt3
13 May 20
Entry into a Material Definitive Agreement
10:59am
8-K
EX-99.1
5uxup0 3bhmw98d6pro
7 May 20
Trovagene Announces First Quarter 2020 Results and Highlights
4:02pm
8-K
EX-99.1
ryg epazjn4g
6 May 20
Trovagene Announces Changing of Company Name to Cardiff Oncology and Appointment of Mark Erlander, PhD, as Chief Executive Officer
10:29am
8-K
EX-99.01
qvs4swrj ntbjg
28 Apr 20
Other Events
12:22pm
8-K
EX-99.01
xxa tqt099x33sbrk70
22 Apr 20
Other Events
10:54am
8-K
EX-10.1
pt6e592qgd
10 Apr 20
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
x9t1c8bu
1 Apr 20
Other Events
1:54pm
8-K
EX-10.1
ubfpdk1v
31 Mar 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
8ngk1zq95 pwkdjqsf2l
5 Mar 20
Trovagene Announces Three New Nominees for Election to Board of Directors
10:38am
8-K
EX-99.1
df4zdg3
27 Feb 20
Trovagene Announces Fourth Quarter and Full-Year 2019 Results
4:15pm
8-K
EX-99.1
7meqz9ues6wll7q66pk
13 Feb 20
Other Events
10:00am
8-K
EX-99.1
jlingh
5 Feb 20
Trovagene to Present New Clinical Data for Onvansertib in Metastatic Castration-Resistant Prostate Cancer at ASCO Genitourinary Cancers Symposium
10:24am
8-K
EX-99.1
hnv2sjopzfztxxy
29 Jan 20
Trovagene Receives Approximately $1.45 Million From Exercise of Warrants
10:51am